← Back

Wire · operational-macro

FDA Clears Next-Generation Device to Capture Embolic Debris During TAVR

Published

19 November 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at nyp.org →

◆ Verified

Fusion42 · 19 November 2026 · Fusion42 review

The FDA has cleared Emboliner, a next-generation embolic protection device designed to capture debris in the entire aortic arch during transcatheter aortic valve replacement (TAVR), demonstrating noninferior safety outcomes and superior debris capture compared to the existing Sentinel device. This technology may expand embolic protection use in high-risk structural heart procedures, addressing an unmet clinical need.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You now have a newly cleared device that offers more complete embolic protection during TAVR and other high-risk heart procedures. This opens a door to expand clinical use and improve patient safety, so consider how your offerings or partnerships might align with this emerging standard.

◆ Coverage

1 source · 19 Nov 2026

◆ Related on Wire

◆ Topics

MedtechFDA-clearanceembolic-protectionTAVRmedical-deviceclinical-trial